107 related articles for article (PubMed ID: 10453447)
1. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling.
Richter M; Ebermann R; Marian B
Nutr Cancer; 1999; 34(1):88-99. PubMed ID: 10453447
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
[TBL] [Abstract][Full Text] [Related]
4. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells.
Chen D; Daniel KG; Chen MS; Kuhn DJ; Landis-Piwowar KR; Dou QP
Biochem Pharmacol; 2005 May; 69(10):1421-32. PubMed ID: 15857606
[TBL] [Abstract][Full Text] [Related]
5. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids suppress androgen-independent human prostate tumor proliferation.
Knowles LM; Zigrossi DA; Tauber RA; Hightower C; Milner JA
Nutr Cancer; 2000; 38(1):116-22. PubMed ID: 11341036
[TBL] [Abstract][Full Text] [Related]
7. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
8. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of myricetin and related flavonols against A2E and light mediated-cell death in bovine retinal primary cell culture.
Laabich A; Manmoto CC; Kuksa V; Leung DW; Vissvesvaran GP; Karliga I; Kamat M; Scott IL; Fawzi A; Kubota R
Exp Eye Res; 2007 Jul; 85(1):154-65. PubMed ID: 17544396
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation.
Huynh H; Nguyen TT; Chan E; Tran E
Int J Oncol; 2003 Sep; 23(3):821-9. PubMed ID: 12888923
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of endothelin 1-stimulated proliferation in colorectal cancer cell lines.
Grant K; Knowles J; Dawas K; Burnstock G; Taylor I; Loizidou M
Br J Surg; 2007 Jan; 94(1):106-12. PubMed ID: 17078114
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2.
Dihal AA; Woutersen RA; van Ommen B; Rietjens IM; Stierum RH
Cancer Lett; 2006 Jul; 238(2):248-59. PubMed ID: 16129554
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
Simpson BJ; Bartlett JM; Macleod KG; Rabiasz G; Miller EP; Rae AL; Gordge P; Leake RE; Miller WR; Smyth J; Langdon SP
Br J Cancer; 1999 Mar; 79(7-8):1098-103. PubMed ID: 10098742
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
18. Quercetin induces necrosis and apoptosis in SCC-9 oral cancer cells.
Haghiac M; Walle T
Nutr Cancer; 2005; 53(2):220-31. PubMed ID: 16573383
[TBL] [Abstract][Full Text] [Related]
19. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
Kim SJ; Uehara H; Karashima T; Shepherd DL; Killion JJ; Fidler IJ
Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
Kim SJ; Uehara H; Yazici S; Langley RR; He J; Tsan R; Fan D; Killion JJ; Fidler IJ
Cancer Res; 2004 Jun; 64(12):4201-8. PubMed ID: 15205332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
